Clinical Trial Update: Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating veverimer to decrease net acid excretion and bone resorption in adults with osteopenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Veverimer

Snippet

Sponsor: Tufts Medical Center | Conditions: Osteopenia | Phase 1 | Status: RECRUITING